Concord Medical Services Holdings Limited (NYSE:CCM) Short Interest Update

Concord Medical Services Holdings Limited (NYSE:CCM – Get Free Report) was the recipient of a significant growth in short interest during the month of July. As of July 31st, there was short interest totaling 4,641 shares, a growth of 55.7% from the July 15th total of 2,980 shares. Based on an average trading volume of 57,272 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.2% of the company’s shares are short sold.

Analyst Ratings Changes

A number of equities analysts have recently commented on the company. Weiss Ratings restated a “sell (e+)” rating on shares of Concord Medical Services in a report on Tuesday, May 26th. Wall Street Zen raised shares of Concord Medical Services to a “hold” rating in a research report on Saturday. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Concord Medical Services has an average rating of “Sell”.

Get Concord Medical Services alerts:

View Our Latest Stock Analysis on CCM

Concord Medical Services Stock Down 1.9%

Shares of NYSE:CCM opened at $4.57 on Wednesday. Concord Medical Services has a one year low of $3.18 and a one year high of $6.98. The business’s 50-day simple moving average is $4.62 and its 200 day simple moving average is $4.29. The company has a current ratio of 0.48, a quick ratio of 0.46 and a debt-to-equity ratio of 1.33.

Concord Medical Services Company Profile

(Get Free Report)

Concord Medical Services Holdings Limited is one of China’s leading providers of radiotherapy equipment and oncology services. The company specializes in supplying and operating advanced radiotherapy machines, including linear accelerators, computed tomography (CT) simulators and brachytherapy units, to public and private hospitals. Through its integrated service model, Concord Medical Services delivers treatment planning, machine maintenance and clinical support to enhance the precision and effectiveness of cancer therapies.

Founded in 1997 and headquartered in Beijing, Concord Medical Services has developed an extensive network of oncology centers across major cities and provinces in China.

See Also

• Five stocks we like better than Concord Medical Services
• The AI Boom Is Turning This Cable Maker Into a Stock to Watch
• A Star Investor Just Trimmed Amazon—Here’s What It means
• Wendy’s Deal Buzz May Give Fast-Food Investors a New Reason to Look
• Home Depot Analysts See a Path to $375 and Beyond

Receive News & Ratings for Concord Medical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concord Medical Services and related companies with MarketBeat.com's FREE daily email newsletter.